Emily C L Wong
Overview
Explore the profile of Emily C L Wong including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
54
Citations
312
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Huan P, Mehta A, Wong E, Dulai P, Marshall J, Reinisch W, et al.
Am J Gastroenterol
. 2025 Feb;
PMID: 39996607
Endoscopic evaluation is valuable in the diagnosis, assessment, and management of Crohn's Disease. The Simple Endoscopic Score for Crohn's Disease (SES-CD) was created using a uniform, linear scoring scale of...
2.
Wong E, Dulai P, Marshall J, Jairath V, Reinisch W, Narula N
J Crohns Colitis
. 2025 Jan;
19(1).
PMID: 39804709
Introduction: In inflammatory bowel disease (IBD), the number of eosinophils increases in the lamina propria of the intestinal tract, but their specific patho-mechanistic role remains unclear. Elevated blood eosinophil counts...
3.
Wong E, Dulai P, Marshall J, Laroux S, Jairath V, Reinisch W, et al.
J Crohns Colitis
. 2024 Nov;
PMID: 39529369
Introduction: The Modified Multiplier of the SES-CD (MM-SES-CD) refines the assessment of endoscopic Crohn's Disease (CD) severity by differentially weighting parameters in the original SES-CD. A threshold of <22.5 for...
4.
Samnani S, Wong E, Hamam H, Dulai P, Marshall J, Jairath V, et al.
J Crohns Colitis
. 2024 Sep;
PMID: 39302135
Background And Aims: Inflammatory bowel disease (IBD) trials often stratify patients by prior biologic exposure, including prior biologic failure or intolerance. This study aimed to assess clinical outcomes in IBD...
5.
Narula N, Hamam H, Liu J, Wong E, Marshall J, Jairath V, et al.
J Crohns Colitis
. 2024 Jun;
18(11):1863-1869.
PMID: 38869911
Introduction: It is unclear if steroid tapering protocols can affect clinical trial outcomes in ulcerative colitis [UC], particularly fixed versus adaptive steroid tapering. Fixed steroid tapering involves incremental dose decreases...
6.
Chhibba T, Wong E, Reinisch W, Targownik L, Narula N
Eur J Gastroenterol Hepatol
. 2024 Mar;
36(6):704-711.
PMID: 38526945
Vedolizumab is a first-line treatment option for ulcerative colitis. There are differences in incidence of ulcerative colitis between males and females, but whether sex affects treatment outcomes is less clear....
7.
Narula N, Wong E, Dulai P, Patel J, Marshall J, Yzet C, et al.
Clin Gastroenterol Hepatol
. 2024 Mar;
22(8):1687-1696.e6.
PMID: 38428709
Background & Aims: We assessed Modified Multiplier Simple Endoscopic Score for Crohn's Disease (MM-SES-CD) and Simple Endoscopic Score for Crohn's Disease (SES-CD) thresholds that are best associated with low likelihood...
8.
Narula N, Wong E, Dulai P, Marshall J, Jairath V, Reinisch W
Am J Gastroenterol
. 2024 Jan;
119(7):1355-1364.
PMID: 38235763
Introduction: Differences in 1-year outcomes among early and delayed responders have been demonstrated with some therapies in ulcerative colitis. However, it is unclear whether similar differences exist in patients with...
9.
Wong E, Gleave A, Marshall J, Narula N
Eur J Gastroenterol Hepatol
. 2023 Aug;
35(10):1131-1136.
PMID: 37577798
Background: Eosinophilic esophagitis (EoE) is a chronic, allergic disease of the esophagus. Current treatment options are limited. One experimental therapy is antibodies against interleukin-5 (IL-5). However, it is unknown why...
10.
Wong E, Dulai P, Marshall J, Jairath V, Reinisch W, Narula N
Clin Gastroenterol Hepatol
. 2023 Jun;
21(13):3387-3396.e1.
PMID: 37391059
Background & Aims: Differences in 1-year outcomes among early compared with delayed responders to vedolizumab have been shown in ulcerative colitis. However, it is unclear whether similar differences exist with...